688606 Stock Overview
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Hangzhou Alltest Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥74.11 |
| 52 Week High | CN¥81.10 |
| 52 Week Low | CN¥46.02 |
| Beta | 0.36 |
| 1 Month Change | 26.81% |
| 3 Month Change | 24.81% |
| 1 Year Change | 23.10% |
| 3 Year Change | -30.34% |
| 5 Year Change | n/a |
| Change since IPO | -36.94% |
Recent News & Updates
Shareholder Returns
| 688606 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.0% | 4.0% | -0.4% |
| 1Y | 23.1% | -16.8% | -14.4% |
Return vs Industry: 688606 exceeded the CN Medical Equipment industry which returned -16.8% over the past year.
Return vs Market: 688606 exceeded the CN Market which returned -14.4% over the past year.
Price Volatility
| 688606 volatility | |
|---|---|
| 688606 Average Weekly Movement | 7.9% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688606's share price has been volatile over the past 3 months.
Volatility Over Time: 688606's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,261 | Fei Gao | www.alltests.com.cn |
Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products. Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters.
Hangzhou Alltest Biotech Co., Ltd. Fundamentals Summary
| 688606 fundamental statistics | |
|---|---|
| Market cap | CN¥5.79b |
| Earnings (TTM) | CN¥180.05m |
| Revenue (TTM) | CN¥754.68m |
32.2x
P/E Ratio7.7x
P/S RatioIs 688606 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688606 income statement (TTM) | |
|---|---|
| Revenue | CN¥754.68m |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥754.68m |
| Other Expenses | CN¥574.63m |
| Earnings | CN¥180.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | 2.30 |
| Gross Margin | 100.00% |
| Net Profit Margin | 23.86% |
| Debt/Equity Ratio | 0.7% |
How did 688606 perform over the long term?
See historical performance and comparison